U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.

Cover of Drugs and Lactation Database (LactMed®)

Drugs and Lactation Database (LactMed®) [Internet].

Show details

Dornase Alfa

Last Revision: June 21, 2021.

Estimated reading time: 1 minute

CASRN: 143831-71-4

Drug Levels and Effects

Summary of Use during Lactation

No information is available on the clinical use of dornase alpha (hamster) during breastfeeding. Because it is a large protein molecule with a molecular weight of about 37,000 Da, the amount in milk is likely to be very low and absorption is unlikely because it is probably destroyed in the infant's gastrointestinal tract. A task force respiratory experts from Europe, Australia and New Zealand found that dornase alfa is compatible with breastfeeding.[1]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

References

1.
Middleton PG, Gade EJ, Aguilera C, et al. ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases. Eur Respir J. 2020;55:1901208. [PubMed: 31699837]

Substance Identification

Substance Name

Dornase Alfa

CAS Registry Number

143831-71-4

Drug Class

Breast Feeding

Lactation

Enzymes

Deoxyribonuclease I

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Copyright Notice

Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.

Bookshelf ID: NBK500602PMID: 29999662

Views

Related information

Similar articles in PubMed

  • Review Factor Xa (recombinant), Inactivated.[Drugs and Lactation Database (...]
    Review Factor Xa (recombinant), Inactivated.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Benralizumab.[Drugs and Lactation Database (...]
    Review Benralizumab.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Vestronidase Alfa.[Drugs and Lactation Database (...]
    Review Vestronidase Alfa.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Agalsidase Beta.[Drugs and Lactation Database (...]
    Review Agalsidase Beta.
    . Drugs and Lactation Database (LactMed®). 2006
  • Review Velaglucerase Alfa.[Drugs and Lactation Database (...]
    Review Velaglucerase Alfa.
    . Drugs and Lactation Database (LactMed®). 2006
See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...